Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein

Journal of Steroid Biochemistry and Molecular Biology

Volumn 118, Issue 1-2, 2010, Pages 1-6

  Kretzschmar, Georg ^a   Zierau, Oliver ^a   Wober, Jannette ^a   Tischer, Sandra ^a   Metz, Peter ^a   Vollmer, Günter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

6 (1,1 Dimethylallyl)genistein; 6 (1,1 Dimethylallyl)naringenin; 8 Prenylgenistein; 8 Prenylnaringenin; Estrogen receptor; Genistein; Ishikawa cells; MVLN cells; Naringenin

Indexed keywords

6 (1,1 DIMETHYLALLYL)GENISTEIN; 6 (1,1 DIMETHYLALLYL)NARINGENIN; 8 PRENYLGENISTEIN; 8 PRENYLNARINGENIN; ALKALINE PHOSPHATASE; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; LUCIFERASE; NARINGENIN; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PLANT METABOLISM; PROTEIN PRENYLATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; YEAST;

ALKALINE PHOSPHATASE; ANIMALS; BETA-GALACTOSIDASE; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FLAVANONES; GENE EXPRESSION; GENES, REPORTER; GENISTEIN; HUMANS; LUCIFERASES; PHYTOESTROGENS; PRENYLATION; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SACCHAROMYCES CEREVISIAE; TRANSFECTION; VITELLOGENINS; XENOPUS;

MAMMALIA;

EID: 72449155036     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.08.005     Document Type: Article

References (27)

1. McLachlan J.A. Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr. Rev. 22 3 (2001) 319-341
2. Carter M.W., Smart Jr. W.W., and Matrone G. Estimation of estrogenic activity of genistein obtained from soybean meal. Proc. Soc. Exp. Biol. Med. 84 2 (1953) 506-508
3. Hsieh C.Y., Santell R.C., Haslam S.Z., and Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58 17 (1998) 3833-3838
4. Diel P., Schmidt S., Vollmer G., Janning P., Upmeier A., Michna H., Bolt H.M., and Degen G.H. Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens. Arch. Toxicol. 78 4 (2004) 183-193
5. Zierau O., Kolba S., Olff S., Vollmer G., and Diel P. Analysis of the promoter-specific estrogenic potency of the phytoestrogens genistein, daidzein and coumestrol. Planta Med. 72 2 (2006) 184-186
6. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., and Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 50 9 (1995) 1485-1493
7. Zand R.S., Jenkins D.J., and Diamandis E.P. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res. Treat. 62 1 (2000) 35-49
8. Breinholt V.M., Svendsen G.W., Dragsted L.O., and Hossaini A. The citrus-derived flavonoid naringenin exerts uterotrophic effects in female mice at human relevant doses. Basic Clin. Pharmacol. Toxicol. 94 1 (2004) 30-36
9. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., Rong H., and De Keukeleire D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 85 12 (2000) 4912-4915
10. Schaefer O., Humpel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 2-3 (2003) 359-360
11. Zierau O., Gester S., Schwab P., Metz P., Kolba S., Wulf M., and Vollmer G. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med. 68 5 (2002) 449-451
12. Zierau O., Kretzschmar G., Moller F., Weigt C., and Vollmer G. Time dependency of uterine effects of naringenin type phytoestrogens in vivo. Mol. Cell. Endocrinol. (2008)
13. Zierau O., Geis R.B., Tischer S., Schwab P., Metz P., and Vollmer G. Uterine effects of the phytoestrogen 6-(1,1-dimethylallyl)naringenin in rats. Planta Med. 70 7 (2004) 590-593
14. Davis S.R., Dalais F.S., Simpson E.R., and Murkies A.L. Phytoestrogens in health and disease. Recent Prog. Horm. Res. 54 (1999) 185-210
15. Gester S., Metz P., Zierau O., and Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin by europium(iii)-catalyzed claisen rearrangement. Tetrahedron 57 (2001) 1015-1018
16. Al-Maharik N., and Botting N.P. Synthesis of lupiwighteone via a para-Claisen-Cope rearrangement. Tetrahedron 59 (2003) 4177-4181
17. S. Tischer, Ph.D. Thesis, TU Dresden, 2007.
18. Routledge E.J., and Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15 (1996) 241-248
19. Pons M., Gagne D., Nicolas J.C., and Mehtali M. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques 9 4 (1990) 450-459
20. Demirpence E., Duchesne M.J., Badia E., Gagne D., and Pons M. MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity. J. Steroid Biochem. Mol. Biol. 46 3 (1993) 355-364
21. Cos P., De Bruyne T., Apers S., Berghe D.V., Pieters L., and Vlietinck A.J. Phytoestrogens: recent developments. Planta Med. 69 7 (2003) 589-599
22. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 6652 (1997) 753-758
23. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., and Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18 17 (1999) 4608-4618
24. Howell A., Osborne C.K., Morris C., and Wakeling A.E. ICI 182, 780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 89 4 (2000) 817-825
25. Wakeling A.E. Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr. Relat. Cancer 7 1 (2000) 17-28
26. Overk C.R., Yao P., Chadwick L.R., Nikolic D., Sun Y., Cuendet M.A., Deng Y., Hedayat A.S., Pauli G.F., Farnsworth N.R., van Breemen R.B., and Bolton J.L. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J. Agric. Food Chem. 53 16 (2005) 6246-6253
27. Albert J.L., Sundstrom S.A., and Lyttle C.R. Estrogen regulation of placental alkaline phosphatase gene expression in a human endometrial adenocarcinoma cell line. Cancer Res. 50 11 (1990) 3306-3310